Ami Organics Limited (BOM:543349)

Market Cap	95.06B
Revenue (ttm)	10.07B
Net Income (ttm)	1.59B
Shares Out	n/a
EPS (ttm)	19.81
PE Ratio	59.89
Forward PE	42.18
Dividend	1.50 (0.13%)
Ex-Dividend Date	n/a

Volume	83,564
Average Volume	29,277
Open	1,141.80
Previous Close	1,130.50
Day's Range	1,125.50 - 1,243.00
52-Week Range	507.23 - 1,321.75
Beta	n/a
RSI	51.98
Earnings Date	May 2, 2025

About Ami Organics

Ami Organics Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson’s, antidepressant, and anticoagulant applications, as well as in new chemical entities. It also provides specialty chemicals for use in agrochemicals, cosmetics, and polymers; and parabens and parabens formulation...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2004
• Employees: 676
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543349

Financial Performance

In 2024, Ami Organics's revenue was 10.07 billion, an increase of 40.34% compared to the previous year's 7.17 billion. Earnings were 1.59 billion, an increase of 271.06%.